PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · عرض على SEC EDGAR ↗ إغلاق أكتوبر 2, 2026 10-K/10-Q أغسطس 6, 2026
$45,26
· % من نطاق 52 أسبوعًا
· فوق الحد الأدنى
· إلى مرتفع
$42,62أدنى 52 أسبوعًا
$71,07أعلى 52 أسبوعًا
القيمة السوقية (الربع الأخير)
$2.55B
P/E (سنوي حالي)
12.7
ربح السهم (سنوي حالي)
$3.57
الإيرادات (سنوي حالي)
$1.10B
شاراتك
نطاق 52 أسبوعًا
$43–$71
تقييم المحللين
BUY
السعر المستهدف
$68
P/E
12.7
ROE
9.1%
هامش صافي الربح
15.6%
شريط الشارات الخاص بك فارغ — قم بتثبيت مقياس في أي مكان على هذه الصفحة.
PBH لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$45.26
القيمة السوقية (الربع الأخير)
$2.55B
P/E (سنوي حالي)
12.7
ربح السهم (سنوي حالي)
$3.57
الإيرادات (سنوي حالي)
$1.10B
ROE (سنوي حالي)
9.1%
D/E الدين/حقوق الملكية (الربع الأخير)
1.1
نطاق 52 أسبوعًا
$43–$71
PBH مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
نطاق
أشرطة
تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.
حول Prestige Consumer Healthcare Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
قطاعHealthcare
صناعةPharmaceuticals
موظفون890
بلدUS
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات$1.09B2017-03-31 → 2026-03-31
ربح السهم$3.912017-03-31 → 2026-03-31
التدفق النقدي الحر$246M2017-03-31 → 2026-03-31
هامش صافي15.6%2017-03-31 → 2026-03-31
التقييم والنسب
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
| المقياس | اتجاه 5 سنوات | PBH | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| P/E (سنوي حالي) | 12.7متوسط 5 سنوات ≈5.5 | ≈5.5 | · | · | |
| السعر/المبيعات (سنوي حالي) | 2.3متوسط 5 سنوات ≈3.3 | ≈3.3 | · | · | |
| السعر / القيمة الدفترية (الربع الأخير) | 1.3متوسط 5 سنوات ≈2.2 | ≈2.2 | · | · | |
| السعر / التدفق النقدي الحر (سنوي حالي) | 10.8متوسط 5 سنوات ≈15.4 | ≈15.4 | · | · | |
| السعر / التدفق النقدي (سنوي حالي) | 10.2متوسط 5 سنوات ≈14.9 | ≈14.9 | · | · | |
| السعر / القيمة الدفترية الملموسة (الربع الأخير) | -1.9 | · | · | · | |
| PEG Ratio (نسبة السعر إلى الأرباح إلى النمو (PEG)) | ≈3.4 | · | · | · |
يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
| المقياس | اتجاه 5 سنوات | PBH | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| هامش الربح الإجمالي (سنوي حالي) | 53.5%متوسط 5 سنوات ≈55.7% | ≈55.7% | · | · | |
| هامش التشغيل (سنوي حالي) | 26.3%متوسط 5 سنوات ≈23.4% | ≈23.4% | · | · | |
| هامش EBITDA (سنوي حالي) | 29.2%متوسط 5 سنوات ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (هامش ما قبل الضريبة) | 23.6%متوسط 5 سنوات ≈17.8% | ≈17.8% | · | · | |
| هامش صافي الربح (سنوي حالي) | 15.6%متوسط 5 سنوات ≈13.3% | ≈13.3% | · | · | |
| العائد على الأصول (سنوي حالي) | 4.3%متوسط 5 سنوات ≈4.3% | ≈4.3% | · | · | |
| ROE (سنوي حالي) | 9.1%متوسط 5 سنوات ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%متوسط 5 سنوات ≈8.6% | ≈8.6% | · | · |
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
| المقياس | اتجاه 5 سنوات | PBH | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| الدين / حقوق الملكية (الربع الأخير) | 1.1متوسط 5 سنوات ≈0.8 | ≈0.8 | · | · | |
| النسبة الحالية (الربع الأخير) | 3.2متوسط 5 سنوات ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio (النسبة السريعة) | 2.1متوسط 5 سنوات ≈1.9 | ≈1.9 | · | · | |
| الدين طويل الأجل / حقوق الملكية (الربع الأخير) | 1.0متوسط 5 سنوات ≈0.8 | ≈0.8 | · | · |
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
| المقياس | اتجاه 5 سنوات | PBH | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Revenue YoY (الإيرادات مقارنة بالعام السابق) | -4.3%متوسط 5 سنوات ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات) | -1.2%متوسط 5 سنوات ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات) | 2.9% | · | · | · | |
| EPS YoY (ربحية السهم على أساس سنوي) | -8.9%متوسط 5 سنوات ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (صافي الدخل مقارنة بالعام السابق) | -11.3%متوسط 5 سنوات ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (متوسط نمو ربحية السهم السنوي لـ 3 سنوات) | 2.0% | · | · | · | |
| EPS CAGR 5Y (متوسط نمو ربحية السهم السنوي لـ 5 سنوات) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (متوسط نمو صافي الدخل السنوي لـ 3 سنوات) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (متوسط نمو صافي الدخل السنوي لـ 5 سنوات) | 2.9% | · | · | · |
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
| المقياس | اتجاه 5 سنوات | PBH | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Asset Turnover (دوران الأصول) | 0.3متوسط 5 سنوات ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (دوران المخزون) | 3.2متوسط 5 سنوات ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (دوران المستحقات) | 5.6متوسط 5 سنوات ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (الإيرادات / الموظف) | ≈$1.2M | · | · | · |
القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.02%
التقرير القادم
نوفمبر 04, 2026
| الفترة | تقرير | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|---|
| 30 يونيو، 2026 | $0.98 | $0.89 | 10.0% | |
| 31 مارس، 2026 | $1.23 | $1.40 | -12.4% | |
| 31 ديسمبر، 2025 | $1.14 | $1.16 | -1.4% | |
| 30 سبتمبر، 2025 | $1.07 | $0.98 | 9.2% | |
| 30 يونيو، 2025 | $0.95 | $1.01 | -6.0% | |
| 31 مارس، 2025 | $1.32 | $1.31 | 0.64% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
الميزانية العمومية
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
التدفق النقدي
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
الربحية
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
السيولة والملاءة
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
الكفاءة
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
لكل سهم
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
معدلات النمو
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
قائمة الدخل
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
الميزانية العمومية
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
التدفق النقدي
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
الربحية
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
السيولة والملاءة
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
الكفاءة
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
لكل سهم
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
| المقياس | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| الإيرادات | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| هامش الربح الإجمالي % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| هامش الربح التشغيلي % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| صافي الدخل | $190M | $215M | $209M | $-82M | $205M |
| EPS المخفف | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| المقياس | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | · | · | 0.7 | 0.9 | 0.9 |
| النسبة الحالية | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| النسبة السريعة | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| المقياس | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $246M | $243M | $239M | $222M | $250M |
الملاك المؤسسيون (13F) 340 مقدمي إقرار · $2.9B إجمالي · حتى تاريخ 30 سبتمبر، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
حائزون
340
القيمة المحتفظ بها
$2.9B
مراكز جديدة
39
المراكز الخارجة
69
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 39 (-19 مقابل الربع السابق) | 69 (+29 مقابل الربع السابق) | 108 (-17 مقابل الربع السابق) | 119 (-10 مقابل الربع السابق) | +2.2M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| BlackRock, Inc. | $370187111 | 7831333 | 12,99% | الأسهم |
| VANGUARD GROUP INC | $332432481 | 5388758 | 11,66% | الأسهم |
| ARIEL INVESTMENTS, LLC | $230143970 | 4868711 | 8,07% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133553822 | 2825340 | 4,69% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $125802061 | 2661291 | 4,41% | الأسهم |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110225175 | 2331821 | 3,87% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $101013343 | 2136944 | 3,54% | الأسهم |
| STATE STREET CORP | $100047570 | 2116513 | 3,51% | الأسهم |
| BRANDES INVESTMENT PARTNERS, LP | $96953606 | 2051060 | 3,40% | الأسهم |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88490528 | 1872023 | 3,10% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $74306032 | 1571742 | 2,61% | الأسهم |
| Allspring Global Investments Holdings, LLC | $61257112 | 1271950 | 2,15% | الأسهم |
| MORGAN STANLEY | $58800671 | 1243931 | 2,06% | الأسهم |
| NORDEA INVESTMENT MANAGEMENT AB | $39252108 | 828628 | 1,38% | الأسهم |
| NORTHERN TRUST CORP | $36560934 | 773449 | 1,28% | الأسهم |
| WESTWOOD HOLDINGS GROUP INC | $35473535 | 750445 | 1,24% | الأسهم |
| RICE HALL JAMES & ASSOCIATES, LLC | $32601741 | 689692 | 1,14% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31134811 | 658659 | 1,09% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30922805 | 654174 | 1,08% | الأسهم |
| UBS Group AG | $30186858 | 638605 | 1,06% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29772348 | 629836 | 1,04% | الأسهم |
| Boston Trust Walden Corp | $28832289 | 609949 | 1,01% | الأسهم |
| GOLDMAN SACHS GROUP INC | $27725541 | 586536 | 0,97% | الأسهم |
| CITADEL ADVISORS LLC | $26667701 | 564157 | 0,94% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $26277109 | 555894 | 0,92% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $21949967 | 464353 | 0,77% | الأسهم |
| Leeward Investments, LLC - MA | $20700289 | 437916 | 0,73% | الأسهم |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19921578 | 421440 | 0,70% | الأسهم |
| Invesco Ltd. | $19209111 | 406370 | 0,67% | الأسهم |
| Woodline Partners LP | $17004012 | 359721 | 0,60% | الأسهم |
| ARMISTICE CAPITAL, LLC | $15882720 | 336000 | 0,56% | الأسهم |
| Glenmede Investment Management, LP | $15685425 | 251369 | 0,55% | الأسهم |
| Bank of New York Mellon Corp | $15375752 | 325275 | 0,54% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $14837438 | 313887 | 0,52% | الأسهم |
| D. E. Shaw & Co., Inc. | $14832286 | 313778 | 0,52% | الأسهم |
| WELLS FARGO & COMPANY/MN | $14604614 | 308962 | 0,51% | الأسهم |
| Nuveen, LLC | $14012435 | 296434 | 0,49% | الأسهم |
| Congress Wealth Management LLC / DE / | $13030320 | 163185 | 0,46% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $12700693 | 268684 | 0,45% | الأسهم |
| Tributary Capital Management, LLC | $11958554 | 252984 | 0,42% | الأسهم |
| Fisher Asset Management, LLC | $11698136 | 247474 | 0,41% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $11013816 | 232998 | 0,39% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $10251209 | 216865 | 0,36% | الأسهم |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10122871 | 214150 | 0,36% | الأسهم |
| JPMORGAN CHASE & CO | $10050950 | 207249 | 0,35% | الأسهم |
| Aristotle Capital Boston, LLC | $10043458 | 212470 | 0,35% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $9983703 | 211206 | 0,35% | الأسهم |
| FMR LLC | $9951172 | 210518 | 0,35% | الأسهم |
| GLENMEDE TRUST CO NA | $9729017 | 205818 | 0,34% | الأسهم |
| JENNISON ASSOCIATES LLC | $9393259 | 198715 | 0,33% | الأسهم |
المطلعون على الشركة 50 من المطلعين · مسؤولون 29 · مديرون 18
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 7 مايو، 2026 F | 373465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 1 يونيو، 2015 M | 27706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 3 مارس، 2009 P | 177168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 مايو، 2006 P | 33278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 2 مايو، 2026 F | 57374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 9 مايو، 2016 A | 11050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 مايو، 2010 D | 401850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 مايو، 2026 S | 41810 | 0 | 7 | $-246374 |
| Adel Mekhail | EVP, Marketing & Sales | 7 مايو، 2026 F | 25703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 4 مايو، 2026 A | 28149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 6 يناير، 2026 A | 3436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 7 مايو، 2025 F | 17051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 9 مايو، 2019 F | 21717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 مايو، 2018 M | 11081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 7 مايو، 2018 A | 8150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 أغسطس، 2017 F | 6678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 مايو، 2017 F | 62075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 مايو، 2016 M | 55927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 مايو، 2016 M | 32176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 مايو، 2014 M | 15282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 مايو، 2011 F | 13236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 مايو، 2010 D | 28331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 مايو، 2010 D | 16640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 مارس، 2009 D | 30579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 مارس، 2009 D | 90846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 مايو، 2008 A | 27427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 2 يناير، 2007 D | 289172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 فبراير، 2005 S | 180560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 فبراير، 2005 S | 72347 | 0 | 0 | $0 |
| Sheila Hopkins | مدير | 5 أغسطس، 2025 A | 30123 | 0 | 0 | $0 |
| Natale S Ricciardi | مدير | 1 أغسطس، 2023 A | 27098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | مدير | 2 أغسطس، 2022 A | 13218 | 0 | 0 | $0 |
| James M Jenness | مدير | 4 أغسطس، 2020 A | 22791 | 0 | 0 | $0 |
| Carl J Johnson | مدير | 31 يوليو، 2018 A | 14598 | 0 | 0 | $0 |
| Charles Hinkaty | مدير | 4 أغسطس، 2015 A | 31714 | 0 | 0 | $0 |
| Patrick Lonergan | مدير | 10 ديسمبر، 2012 G | 37323 | 0 | 0 | $0 |
| John Byom | مدير | 3 أغسطس، 2010 A | 29755 | 0 | 0 | $0 |
| Vincent J Hemmer | مدير | 10 سبتمبر، 2009 J | 80410 | 0 | 0 | $0 |
| Peter Mann | مدير | 4 أغسطس، 2009 A | 447700 | 0 | 0 | $0 |
| Dick L Buell | مدير | 4 أغسطس، 2009 A | 27662 | 0 | 0 | $0 |
| David Donnini | مدير | 29 مايو، 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | مدير | 5 أغسطس، 2008 A | 30352 | 0 | 0 | $0 |
| Raymond Silcock | مدير | 5 أغسطس، 2008 A | 16249 | 0 | 0 | $0 |
| John F. Kelly | · | 4 أغسطس، 2026 A | 7832 | 0 | 0 | $0 |
| James Darecca | · | 4 أغسطس، 2026 A | 9572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 4 أغسطس، 2026 A | 19514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 4 أغسطس، 2026 A | 16511 | 0 | 0 | $0 |
| John E Byom | · | 4 أغسطس، 2026 A | 54575 | 0 | 1 | $-178050 |
| COSTLEY GARY E | · | 4 أغسطس، 2020 A | 50200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 مايو، 2009 S | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 67 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,83% | 347516 SH | 2 أكتوبر، 2026 | يومي |
| PILL · Direxion Shares ETF Trust | 1,16% | 4781 NS | 31 يوليو، 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 44987 SH | 2 أكتوبر، 2026 | يومي |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5597 NS | 31 يوليو، 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25280 NS | 31 يوليو، 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 يوليو، 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3105 NS | 31 يوليو، 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175342 SH | 11 سبتمبر، 2026 | يومي |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92272 NS | 31 يوليو، 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181211 NS | 31 يوليو، 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100520 SH | 19 أغسطس، 2026 | يومي |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18534 NS | 31 يوليو، 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41965 SH | 19 أغسطس، 2026 | يومي |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7601 SH | 2 أكتوبر، 2026 | يومي |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4372 NS | 31 يوليو، 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165811 SH | 19 أغسطس، 2026 | يومي |
| ROSC · Lattice Strategies Trust | 0,12% | 1466 NS | 31 يوليو، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195077 NS | 31 يوليو، 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8172 SH | 2 أكتوبر، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 66578 SH | 2 أكتوبر، 2026 | يومي |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 يوليو، 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1747 NS | 31 يوليو، 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43685 NS | 31 يوليو، 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11789 NS | 31 يوليو، 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7246 SH | 19 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,08% | 22923 NS | 31 يوليو، 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1227360 SH | 11 سبتمبر، 2026 | يومي |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175325 SH | 19 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275721 SH | 19 أغسطس، 2026 | يومي |
| DFAT · Dimensional ETF Trust | 0,07% | 196959 NS | 31 يوليو، 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28777 SH | 2 أكتوبر، 2026 | يومي |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690582 SH | 19 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,05% | 152317 NS | 31 يوليو، 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10967 SH | 11 سبتمبر، 2026 | يومي |
| WSML · iShares Trust | 0,04% | 5420 SH | 11 سبتمبر، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22700 NS | 31 يوليو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544134 SH | 19 أغسطس، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1087231 SH | 19 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,03% | 142413 SH | 19 أغسطس، 2026 | يومي |
| DFAC · Dimensional ETF Trust | 0,01% | 117382 NS | 31 يوليو، 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36640 NS | 31 يوليو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5233 NS | 31 يوليو، 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688472 SH | 19 أغسطس، 2026 | يومي |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453610 SH | 19 أغسطس، 2026 | يومي |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9203 SH | 19 أغسطس، 2026 | يومي |
| IDEV · iShares Trust | 0,01% | 52014 SH | 11 سبتمبر، 2026 | يومي |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 يوليو، 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3004 NS | 31 يوليو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4442 NS | 31 يوليو، 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56667 SH | 11 سبتمبر، 2026 | يومي |
| ITOT · iShares Trust | 0,00% | 69137 SH | 11 سبتمبر، 2026 | يومي |
| IWV · iShares Trust | 0,00% | 14019 SH | 11 سبتمبر، 2026 | يومي |
| DFAU · Dimensional ETF Trust | 0,00% | 6651 NS | 31 يوليو، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10940 NS | 31 يوليو، 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1510012 SH | 19 أغسطس، 2026 | يومي |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69368 SH | 19 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4089 SH | 19 أغسطس، 2026 | يومي |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10506 SH | 19 أغسطس، 2026 | يومي |
| IJR · iShares Trust | · | 2889316 SH | 10 سبتمبر، 2026 | يومي |
| IJS · iShares Trust | · | 422466 SH | 8 سبتمبر، 2026 | يومي |
| IWN · iShares Trust | · | 449434 SH | 11 سبتمبر، 2026 | يومي |
| XJR · iShares Trust | · | 6541 SH | 31 أغسطس، 2026 | يومي |
| SVAL · iShares Trust | · | 10792 SH | 3 سبتمبر، 2026 | يومي |
| ISCB · iShares Trust | · | 1977 SH | 11 سبتمبر، 2026 | يومي |
| ISCV · iShares Trust | · | 9565 SH | 11 سبتمبر، 2026 | يومي |
| SMLF · iShares Trust | · | 38488 SH | 11 سبتمبر، 2026 | يومي |
| SMMV · iShares Trust | · | 20132 SH | 25 أغسطس، 2026 | يومي |
PBH توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
تصنيف · 10 محللين
شراء
السعر المستهدف الوسيط
$70.00
+54,7%
3 30,0%
شراء قوي
4 40,0%
شراء
3 30,0%
احتفاظ
0 0,0%
بيع
0 0,0%
بيع قوي
السعر المستهدف لمدة 12 شهرًا
5 محللين · 2026-10-03السعر المستهدف المتوسط $67.80 +49,8%
← أقل من جميع الأهداف
السعر الحالي $45.26
منخفض$55.00
المتوسط$67.80
مرتفع$75.00
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
المصدر: إيداع SEC 10-Q بتاريخ أغسطس 6, 2026